|
 |
Webinar: Oncogenic Role of KDM1A in Chronic Lymphocytic Leukemia (CLL)
Dr. Qu Jiang, University Hospital of Leipzig, presents her research based on a recent paper on the role of the demethylase KDM1A in chronic lymphocytic leukemia (CLL). Using the image analysis solution StrataQuest the team could automatically analyze the immunofluorescent staining of murine spleen sections and evaluate the leukemic burden upon knockdown of Kdm1a.
|
 |
Novel Cancer-Associated Fibroblast (CAF) Subset in HNSCC
In HNSCC CD8+ T-cell tumor infiltration is often dysfunctional. Chuwen Li et al. performed mIF staining of three immune types, which they had also studied using spatial transcriptomics. With TissueFAXS Spectra slide scanner and StrataQuest the team captured whole-slide multispectral images and analyzed the distribution of Gal9+ CAF and CD8+ T cells.
|
 |
Unlocking the Potential of HHLA2 in Laryngeal Squamous Cell Carcinoma
HHLA2 is investigated as a prognostic marker in some cancer types, including LSCC. To study its role in immune cells, the researchers conducted multiplexed immunohistochemistry analyses on TMA cores, which were then acquired by the TissueFAXS automated microscopy system. StrataQuest analysis software was then used to assess HHLA2 expression in various immune cells.
|
 |
Meet Us at the Annual Scientific Meeting of the Australian and New Zealand Society for Immunology (ASI)
We are glad to announce that TissueGnostics is the Platinum sponsor of the esteemed ASI meeting, which will take place from 25th – 29th November 2024 in Sydney, Australia. Don’t forget to register for one of the biggest immunological meetings in Australasian region and come by to talk to our team about your imaging needs.
|
 |
Call for Papers: Cancer Organoid Co-Culture Models for Enhanced Cancer Research and Modelling
Frontiers in Medicine journal just launched a call for papers with Uwe Ritter (LIT), Talita Glaser (Rutgers) and Rupert Ecker (CEO TissueGnostics) as Topic Editors. This Research Topic aims to explore the advancements and applications of cancer organoid co-culture models in precision medicine. The manuscript submission deadline is until 03.03.2025.
|
|
|
